ABS Capital Partners

June 2017

  • Tuesday, June 13, 2017

    ABS Capital adds LabConnect to portfolio of growth company investments

    LABCONNECT, INC., ANNOUNCES $24.5 MILLION IN SERIES A FUNDING Company‚Äôs strong growth and technical expertise in managing clinical trials attracts […]

    read more